Woodline Partners »

Crescent Biopharma shares owned by Woodline Partners

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $878k 74k 11.86

More positions owned by Woodline Partners

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Verizon Communications (VZ)
Revolution Medicines (RVMD)

View all positions for Woodline Partners

Top funds holding Crescent Biopharma

Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Vestal Point Capital
FMR
BVF
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Perceptive Advisors
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma